Molecular mechanisms that regulate lysosomal protein transport

调节溶酶体蛋白转运的分子机制

基本信息

  • 批准号:
    9892564
  • 负责人:
  • 金额:
    $ 4.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The long-term goal of this proposal is to define molecular mechanisms that regulate the trafficking of integral membrane proteins to the lysosome for degradation. The ESCRT machinery, a set of conserved endosomal protein complexes, is proposed to bind directly to ubiquitinylated membrane proteins and govern their entry into vesicles that bud into the lumen of specialized multivesicular endosomes (MVEs). This process is particularly important for the downregulation of hormone receptors and to prevent constitutive signaling, which can lead to developmental abnormalities and disease. How the late-acting components of the ESCRT machinery coordinate the formation of intralumenal vesicles at MVEs will be addressed in this proposal. The C. elegans germline and early embryo are powerful model systems to study membrane dynamics in an intact, developing animal. Specific proteins can be efficiently depleted from oocytes using RNA interference. Additionally, oocyte maturation and fertilization reproducibly trigger the internalization and ESCRT-mediated degradation of multiple transmembrane proteins, providing an ideal, physiologically relevant system for studying lysosomal protein transport. C. elegans is highly amenable to genetic manipulation and can be engineered easily to stably express transgenes for gene replacement strategies. Additionally, we have established methods to high pressure freeze animals at specific timepoints during embryo development to enable the stepwise characterization of de novo MVE biogenesis using electron microscopy (EM)-based approaches. Given the stereotypic nature of early embryo development, we can correlate these EM data directly with our findings using live cell imaging assays, which we have pioneered in this system. Taking advantage of this unique combination of attributes, the specific aims of this first renewal application are to: 1) define regulatory mechanisms that specify the site of ILV formation on MVEs, 2) determine mechanisms that promote the nucleation of ESCRT-III filaments, and 3) define regulatory mechanisms that control ESCRT-III polymer dynamics. The genetic and biochemical studies conducted during the first period of grant support defined new methods and tools to study ESCRT-III polymer assembly, raising intriguing hypotheses regarding how this process is controlled. Using a combination of in silico molecular modeling, in vitro reconstitution experiments, and in vivo high resolution microscopy-based assays, we will define new mechanisms that regulate ESCRT-III complex assembly during MVE formation. These studies will provide a key framework for future investigation into highly related pathways in mammalian cells.
摘要 这项提案的长期目标是确定调节整合素转运的分子机制。 膜蛋白被运送到溶酶体进行降解。ESCRT机制,一套保守的内体 蛋白复合物,被认为是直接结合到泛素化的膜蛋白,并控制他们的进入 进入囊泡,芽入特化多囊内体(MVEs)的腔中。这个过程是 对于激素受体的下调和防止组成性信号传导特别重要, 会导致发育异常和疾病ESCRT的晚期作用成分 机械协调MVE管腔内囊泡的形成将在本提案中得到解决。梭 线虫种系和早期胚胎是研究完整细胞膜动力学的有力模型系统, 发展中的动物利用RNA干扰可以有效地从卵母细胞中去除特定的蛋白质。 此外,卵母细胞成熟和受精可重复地触发内化和ESCRT介导的 降解多个跨膜蛋白,提供了一个理想的,生理相关的系统, 研究溶酶体蛋白质运输C.秀丽隐杆线虫非常适合基因操作, 易于工程化以稳定表达用于基因置换策略的转基因。此外,我们还有 在胚胎发育期间的特定时间点高压冷冻动物的既定方法, 使用基于电子显微镜(EM)的逐步表征从头MVE生物发生 接近。考虑到早期胚胎发育的固有性质,我们可以将这些EM数据 直接与我们的发现使用活细胞成像分析,这是我们在这个系统中开创的。以 利用这种独特的属性组合,第一次更新申请的具体目标是:1) 定义指定MVE上ILV形成位点的调节机制,2)确定 促进ESCRT-III丝的成核,和3)定义控制ESCRT-III的调节机制 聚合物动力学在第一个资助期内进行的遗传和生化研究 定义了新的方法和工具来研究ESCRT-III聚合物组装,提出了有趣的假设, 这个过程是如何控制的。使用计算机分子建模、体外重构 实验,并在体内高分辨率显微镜为基础的测定,我们将定义新的机制, 在MVE形成过程中调节ESCRT-III复合物组装。这些研究将提供一个关键框架, 进一步研究哺乳动物细胞中高度相关的通路。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hrs and STAM function synergistically to bind ubiquitin-modified cargoes in vitro.
  • DOI:
    10.1016/j.bpj.2014.11.004
  • 发表时间:
    2015-01
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Hirohide Takahashi;J. Mayers;Lei Wang;J. Edwardson;A. Audhya
  • 通讯作者:
    Hirohide Takahashi;J. Mayers;Lei Wang;J. Edwardson;A. Audhya
Phosphoinositide signaling during membrane transport in Saccharomyces cerevisiae.
酿酒酵母膜转运过程中的磷酸肌醇信号传导。
  • DOI:
    10.1007/978-94-007-3015-1_2
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Schuh,AmberL;Audhya,Anjon
  • 通讯作者:
    Audhya,Anjon
The midbody ring scaffolds the abscission machinery in the absence of midbody microtubules.
  • DOI:
    10.1083/jcb.201306036
  • 发表时间:
    2013-11-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Green RA;Mayers JR;Wang S;Lewellyn L;Desai A;Audhya A;Oegema K
  • 通讯作者:
    Oegema K
Regulated lipid synthesis and LEM2/CHMP7 jointly control nuclear envelope closure
  • DOI:
    10.1083/jcb.201908179
  • 发表时间:
    2020-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lauren Penfield;Raakhee Shankar;E. Szentgyörgyi;A. Laffitte;M. Mauro;A. Audhya;T. Müller-Reichert;Shirin Bahmanyar
  • 通讯作者:
    Lauren Penfield;Raakhee Shankar;E. Szentgyörgyi;A. Laffitte;M. Mauro;A. Audhya;T. Müller-Reichert;Shirin Bahmanyar
The ESCRT machinery: from the plasma membrane to endosomes and back again.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anjon Audhya其他文献

Anjon Audhya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anjon Audhya', 18)}}的其他基金

Mechanisms Underlying Axonopathy in Hereditary Spastic Paraplegia
遗传性痉挛性截瘫轴突病的潜在机制
  • 批准号:
    10611493
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
Mechanisms Underlying Axonopathy in Hereditary Spastic Paraplegia
遗传性痉挛性截瘫轴突病的潜在机制
  • 批准号:
    10463959
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
  • 批准号:
    10175159
  • 财政年份:
    2021
  • 资助金额:
    $ 4.77万
  • 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
  • 批准号:
    10402849
  • 财政年份:
    2021
  • 资助金额:
    $ 4.77万
  • 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
  • 批准号:
    10612465
  • 财政年份:
    2021
  • 资助金额:
    $ 4.77万
  • 项目类别:
Molecular mechanisms that regulate vesicle formation and transport
调节囊泡形成和运输的分子机制
  • 批准号:
    10551323
  • 财政年份:
    2020
  • 资助金额:
    $ 4.77万
  • 项目类别:
Molecular mechanisms that regulate vesicle formation and transport
调节囊泡形成和运输的分子机制
  • 批准号:
    10333222
  • 财政年份:
    2020
  • 资助金额:
    $ 4.77万
  • 项目类别:
Molecular mechanisms that regulate vesicle formation and transport
调节囊泡形成和运输的分子机制
  • 批准号:
    10163556
  • 财政年份:
    2020
  • 资助金额:
    $ 4.77万
  • 项目类别:
Administrative Supplement: Molecular mechanisms that regulate vesicle formation and transport
行政补充:调节囊泡形成和运输的分子机制
  • 批准号:
    10796154
  • 财政年份:
    2020
  • 资助金额:
    $ 4.77万
  • 项目类别:
Molecular mechanisms that regulate vesicle formation and transport
调节囊泡形成和运输的分子机制
  • 批准号:
    10093102
  • 财政年份:
    2020
  • 资助金额:
    $ 4.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了